ENDPOINTS

Samsung Biologics to separate manufacturing and biosimilar businesses

Samsung Biologics is splitting apart its contract manufacturing and biosimilar development activities in a bid to enhance their competitiveness. Samsung Bio will become a pure-play CDMO while a new spinoff will focus on biosimilar work ...

May 22, 2025 - 11:54
 0
Samsung Biologics to separate manufacturing and biosimilar businesses
Samsung Biologics is splitting apart its contract manufacturing and biosimilar development activities in a bid to enhance their competitiveness. Samsung Bio will become a pure-play CDMO while a new spinoff will focus on biosimilar work ...
Read More

Tags:

Previous Article

Four-year-old discovers new fish in Kerala: Green Humour by Rohan Chakravarty

Next Article

How to Configure a Wavlink WiFi Router

Related Posts

Dutch biotech Azafaros gets $146M for Phase 3 trials in three metabolic disorders

Dutch biotech Azafaros gets $146M for Phase 3 trials in...

May 13, 2025  0

How PureTech’s lung fibrosis drug stacks up against the competition

How PureTech’s lung fibrosis drug stacks up against the...

May 21, 2025  0

Why Regeneron is buying 23andMe

Why Regeneron is buying 23andMe

May 19, 2025  0